Getinge Industrier AB logo

Getinge Industrier AB (GNGBF)

Market Closed
6 Jun, 20:00
OTC PINK OTC PINK
$
21. 11
0
0%
$
5.14B Market Cap
24.02 P/E Ratio
1.67% Div Yield
0 Volume
0 Eps
$ 21.11
Previous Close
Day Range
21.11 21.11
Year Range
15.62 21.95
Earnings results expected in 40 days

Summary

GNGBF closed yesterday higher at $21.11, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, GNGBF stock gained 35.15%.
GNGBF pays dividends to its shareholders, with the most recent payment made on Apr 29, 2025. The next estimated payment will be in In 10 months on Apr 29, 2026 for a total of $0.4784.
The last earnings report, released on Apr 21, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.08%, based on the last three reports. The next scheduled earnings report is due on Jul 18, 2025.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
Want to track GNGBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

GNGBF Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Getinge AB (publ) (GNGBF) Q1 2025 Earnings Call Transcript

Getinge AB (publ) (GNGBF) Q1 2025 Earnings Call Transcript

Getinge AB (publ) (OTCPK:GNGBF) Q1 2025 Earnings Conference Call April 22, 2025 7:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - Chief Financial Officer Conference Call Participants Rickard Anderkrans - Handelsbanken Mattias Vadsten - SEB Erik Cassel - Danske Bank Markets Kristofer Liljeberg-Svensson - Carnegie Investment Bank Sten Gustafsson - ABG Sundal Collier Aisyah Noor - Morgan Stanley David Adlington - JPMorgan Operator Welcome to the Getinge Q1 Report 2025. [Operator Instructions].

Seekingalpha | 1 month ago
Getinge AB (GNGBF) Q4 2024 Earnings Call Transcript

Getinge AB (GNGBF) Q4 2024 Earnings Call Transcript

Getinge AB (OTCPK:GNGBF) Q4 2024 Results Conference Call January 28, 2025 4:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Rickard Anderkrans - Handelsbanken Erik Cassel - Danske Bank Aisyah Noor - MS Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Investment Bank Patrik Ling - DNB Markets Operator Welcome to the Getinge Q4 Report 2024. [Operator Instructions] Now I will hand the conference over to speakers CEO, Mattias Perjos; and CFO, Agneta Palmer.

Seekingalpha | 4 months ago
Getinge AB (GNGBF) Q3 2024 Earnings Call Transcript

Getinge AB (GNGBF) Q3 2024 Earnings Call Transcript

Getinge AB (OTCPK:GNGBF) Q3 2024 Earnings Conference Call October 18, 2024 4:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Erik Cassel - Danske Bank Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Investment Bank David Johansson - Nordea Markets Aisyah Noor - Morgan Stanley Oliver Reinberg - Kepler Cheuvreux David Adlington - JPMorgan Sten Gustafsson - ABG Sundal Collier Rickard Anderkrans - Handelsbanken Aisyah Noor - Morgan Stanley Kristofer Liljeberg - Carnegie Investment Bank Operator Welcome to the Getinge Q3 Report 2023. [Operator Instructions].

Seekingalpha | 7 months ago

Getinge Industrier AB Dividends

Getinge Industrier AB logo
GNGBF In 10 months
Estimated
Annual
$0.48 Per Share
Getinge Industrier AB logo
GNGBF 1 month ago
Paid
Annual
$0.48 Per Share
Getinge Industrier AB logo
GNGBF 23 Apr 2024
Paid
Annual
$0 Per Share
Getinge Industrier AB logo
GNGBF 27 Apr 2023
Paid
Annual
$0 Per Share
Getinge Industrier AB logo
GNGBF 27 Apr 2022
Paid
Annual
$0 Per Share
Getinge Industrier AB logo
GNGBF 21 Apr 2021
Paid
Annual
$0 Per Share

Getinge Industrier AB Earnings

18 Jul 2025 (40 Days) Date
-
Cons. EPS
-
EPS
21 Apr 2025 Date
-
Cons. EPS
-
EPS
28 Jan 2025 Date
-
Cons. EPS
0.23
EPS
18 Oct 2024 Date
-
Cons. EPS
0
EPS
18 Jul 2024 Date
-
Cons. EPS
0.18
EPS
Getinge Industrier AB logo
GNGBF In 10 months
Estimated
Annual
$0.48 Per Share
Getinge Industrier AB logo
GNGBF 1 month ago
Paid
Annual
$0.48 Per Share
Getinge Industrier AB logo
GNGBF 23 Apr 2024
Paid
Annual
$0 Per Share
Getinge Industrier AB logo
GNGBF 27 Apr 2023
Paid
Annual
$0 Per Share
Getinge Industrier AB logo
GNGBF 27 Apr 2022
Paid
Annual
$0 Per Share
Getinge Industrier AB logo
GNGBF 21 Apr 2021
Paid
Annual
$0 Per Share
18 Jul 2025 (40 Days) Date
-
Cons. EPS
-
EPS
21 Apr 2025 Date
-
Cons. EPS
-
EPS
28 Jan 2025 Date
-
Cons. EPS
0.23
EPS
18 Oct 2024 Date
-
Cons. EPS
0
EPS
18 Jul 2024 Date
-
Cons. EPS
0.18
EPS

Getinge Industrier AB (GNGBF) FAQ

What is the stock price today?

The current price is $21.11.

On which exchange is it traded?

Getinge Industrier AB is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is GNGBF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 5.14B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 18, 2025.

Has Getinge Industrier AB ever had a stock split?

No, there has never been a stock split.

Getinge Industrier AB Profile

Medical - Devices Industry
Healthcare Sector
Mr. Mattias Perjos M.Sc. CEO
OTC PINK Exchange
SE0000202624 ISIN
SE Country
11,827 Employees
24 Apr 2025 Last Dividend
- Last Split
- IPO Date

Overview

Getinge AB (publ) is a global provider of products and solutions targeted at improving efficiencies and outcomes in operating rooms, intensive-care units, sterilization departments, and more. Established in 1904 and based in Gothenburg, Sweden, the company enriches healthcare facilities worldwide through its three operative segments: Acute Care Therapies, Life Science, and Surgical Workflows. It is dedicated to offering a wide range of medical technologies and services, catering to the critical areas of patient care and scientific processes. Getinge stands out for its comprehensive product portfolio that addresses complex healthcare challenges, aiming for innovation in patient care and clinical results. The company extends its reach through an extensive network of sales companies and partners across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions, ensuring its solutions are accessible globally.

Products and Services

  • Extracorporeal membrane oxygenation (ECMO), mechanical ventilation, and mechanical circulatory support:

    These are life-saving therapies for patients in critical conditions, offering support for heart and lung functions.

  • Advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions:

    Comprehensive patient monitoring and management systems designed for the intensive care environment, improving patient flow and care efficiency.

  • Surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions:

    Essential tools and technologies for cardiac surgery, enhancing surgical outcomes and patient recovery.

  • Operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions:

    State-of-the-art solutions for the operating room, facilitating better coordination, safety, and efficiency during surgical procedures.

  • Pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices:

    Comprehensive infection control solutions that ensure the cleanliness and sterility of medical devices and environments, backed by advanced connectivity for seamless operations.

  • Bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers:

    Advanced solutions supporting the life science industry in drug development and manufacturing processes with a focus on sterility and containment.

  • Vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions:

    Equipment and systems designed for research labs and bioprocessing facilities, ensuring safe handling of materials and sterility for bioprocessing applications.

Contact Information

Address: Lindholmspiren 7A
Phone: 46 1 03 35 00 00